Literature DB >> 25567773

The interactions between alcohol consumption and DNA methylation of the ADD1 gene promoter modulate essential hypertension susceptibility in a population-based, case-control study.

Liyuan Han1, Panpan Liu2, Changyi Wang3, Qilong Zhong1, Rui Fan1, Lin Wang1, Shiwei Duan1, Lina Zhang1.   

Abstract

The potential effects of the interactions between DNA methylation (CpG1 and CpG2-5 methylation levels) of the α-adducin (ADD1) gene promoter and ADD1 tagSNPs (tag single-nucleotide polymorphisms) or the environmental factors on essential hypertension (EH) risk have not been clarified. Thus, we performed an age- and gender-matched case-control study to investigate the association between ADD1 tagSNPs and EH. A total of 1020 subjects with EH and 1020 normotensive subjects were genotyped by melting temperature shift technology. Logistic regression was used to assess the associations of ADD1 tagSNPs, environmental factors and EH. The generalized multifactor dimensionality reduction (GMDR) method was applied to explore the potential interactions. Under additive, dominant and recessive models, no significant associations were evidenced between EH and rs3755885, rs2071694, rs4963 or rs3775067 with the complete data set or the gender-stratified analysis after adjusting for triglycerides, body mass index and alcohol consumption. However, we observed a significant association between rs4961 and EH under the dominant model after Bonferroni correction when adjusting for confounding factors in the entire sample (odds ratio (OR)=0.64, 95% confidence interval (CI)=0.50-0.83, P=0.001). In GMDR, the two-factor interaction model of alcohol consumption and DNA methylation (CpG1 methylation) was the best model, with a maximum cross-validation consistency of 9/10 and testing balance accuracy of 0.63 (P=0.01). Our results indicate that the SNP rs4961 has a protective role in the development of EH. In conclusion, the interactions between alcohol consumption and DNA methylation (CpG1 methylation) of the ADD1 gene promoter have a significant role in modifying EH susceptibility.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25567773     DOI: 10.1038/hr.2014.172

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  30 in total

1.  Segmental copy number variation shapes tissue transcriptomes.

Authors:  Charlotte N Henrichsen; Nicolas Vinckenbosch; Sebastian Zöllner; Evelyne Chaignat; Sylvain Pradervand; Frédéric Schütz; Manuel Ruedi; Henrik Kaessmann; Alexandre Reymond
Journal:  Nat Genet       Date:  2009-03-08       Impact factor: 38.330

Review 2.  Genetic biomarkers of hypertension and future challenges integrating epigenomics.

Authors:  Said El Shamieh; Sophie Visvikis-Siest
Journal:  Clin Chim Acta       Date:  2012-09-23       Impact factor: 3.786

3.  Computational study of ADD1 gene polymorphism associated with hypertension.

Authors:  Arpita Kundu; Anbarasu Anand
Journal:  Cell Biochem Biophys       Date:  2013-01       Impact factor: 2.194

Review 4.  Epigenomics of hypertension.

Authors:  Mingyu Liang; Allen W Cowley; David L Mattson; Theodore A Kotchen; Yong Liu
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

Review 5.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

6.  Dimethyl sulfoxide has an impact on epigenetic profile in mouse embryoid body.

Authors:  Misa Iwatani; Kohta Ikegami; Yuliya Kremenska; Naka Hattori; Satoshi Tanaka; Shintaro Yagi; Kunio Shiota
Journal:  Stem Cells       Date:  2006-07-13       Impact factor: 6.277

7.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Stephen S Lim; Theo Vos; Abraham D Flaxman; Goodarz Danaei; Kenji Shibuya; Heather Adair-Rohani; Markus Amann; H Ross Anderson; Kathryn G Andrews; Martin Aryee; Charles Atkinson; Loraine J Bacchus; Adil N Bahalim; Kalpana Balakrishnan; John Balmes; Suzanne Barker-Collo; Amanda Baxter; Michelle L Bell; Jed D Blore; Fiona Blyth; Carissa Bonner; Guilherme Borges; Rupert Bourne; Michel Boussinesq; Michael Brauer; Peter Brooks; Nigel G Bruce; Bert Brunekreef; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Fiona Bull; Richard T Burnett; Tim E Byers; Bianca Calabria; Jonathan Carapetis; Emily Carnahan; Zoe Chafe; Fiona Charlson; Honglei Chen; Jian Shen Chen; Andrew Tai-Ann Cheng; Jennifer Christine Child; Aaron Cohen; K Ellicott Colson; Benjamin C Cowie; Sarah Darby; Susan Darling; Adrian Davis; Louisa Degenhardt; Frank Dentener; Don C Des Jarlais; Karen Devries; Mukesh Dherani; Eric L Ding; E Ray Dorsey; Tim Driscoll; Karen Edmond; Suad Eltahir Ali; Rebecca E Engell; Patricia J Erwin; Saman Fahimi; Gail Falder; Farshad Farzadfar; Alize Ferrari; Mariel M Finucane; Seth Flaxman; Francis Gerry R Fowkes; Greg Freedman; Michael K Freeman; Emmanuela Gakidou; Santu Ghosh; Edward Giovannucci; Gerhard Gmel; Kathryn Graham; Rebecca Grainger; Bridget Grant; David Gunnell; Hialy R Gutierrez; Wayne Hall; Hans W Hoek; Anthony Hogan; H Dean Hosgood; Damian Hoy; Howard Hu; Bryan J Hubbell; Sally J Hutchings; Sydney E Ibeanusi; Gemma L Jacklyn; Rashmi Jasrasaria; Jost B Jonas; Haidong Kan; John A Kanis; Nicholas Kassebaum; Norito Kawakami; Young-Ho Khang; Shahab Khatibzadeh; Jon-Paul Khoo; Cindy Kok; Francine Laden; Ratilal Lalloo; Qing Lan; Tim Lathlean; Janet L Leasher; James Leigh; Yang Li; John Kent Lin; Steven E Lipshultz; Stephanie London; Rafael Lozano; Yuan Lu; Joelle Mak; Reza Malekzadeh; Leslie Mallinger; Wagner Marcenes; Lyn March; Robin Marks; Randall Martin; Paul McGale; John McGrath; Sumi Mehta; George A Mensah; Tony R Merriman; Renata Micha; Catherine Michaud; Vinod Mishra; Khayriyyah Mohd Hanafiah; Ali A Mokdad; Lidia Morawska; Dariush Mozaffarian; Tasha Murphy; Mohsen Naghavi; Bruce Neal; Paul K Nelson; Joan Miquel Nolla; Rosana Norman; Casey Olives; Saad B Omer; Jessica Orchard; Richard Osborne; Bart Ostro; Andrew Page; Kiran D Pandey; Charles D H Parry; Erin Passmore; Jayadeep Patra; Neil Pearce; Pamela M Pelizzari; Max Petzold; Michael R Phillips; Dan Pope; C Arden Pope; John Powles; Mayuree Rao; Homie Razavi; Eva A Rehfuess; Jürgen T Rehm; Beate Ritz; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Jose A Rodriguez-Portales; Isabelle Romieu; Robin Room; Lisa C Rosenfeld; Ananya Roy; Lesley Rushton; Joshua A Salomon; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; Amir Sapkota; Soraya Seedat; Peilin Shi; Kevin Shield; Rupak Shivakoti; Gitanjali M Singh; David A Sleet; Emma Smith; Kirk R Smith; Nicolas J C Stapelberg; Kyle Steenland; Heidi Stöckl; Lars Jacob Stovner; Kurt Straif; Lahn Straney; George D Thurston; Jimmy H Tran; Rita Van Dingenen; Aaron van Donkelaar; J Lennert Veerman; Lakshmi Vijayakumar; Robert Weintraub; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Warwick Williams; Nicholas Wilson; Anthony D Woolf; Paul Yip; Jan M Zielinski; Alan D Lopez; Christopher J L Murray; Majid Ezzati; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

8.  Two point mutations within the adducin genes are involved in blood pressure variation.

Authors:  G Bianchi; G Tripodi; G Casari; S Salardi; B R Barber; R Garcia; P Leoni; L Torielli; D Cusi; M Ferrandi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey.

Authors:  Jinwei Wang; Luxia Zhang; Fang Wang; Lisheng Liu; Haiyan Wang
Journal:  Am J Hypertens       Date:  2014-04-03       Impact factor: 2.689

10.  A genome-wide methylation study on essential hypertension in young African American males.

Authors:  Xiaoling Wang; Bonita Falkner; Haidong Zhu; Huidong Shi; Shaoyong Su; Xiaojing Xu; Ashok Kumar Sharma; Yanbin Dong; Frank Treiber; Bernard Gutin; Gregory Harshfield; Harold Snieder
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

View more
  7 in total

1.  Old-style epidemiology and epigeneticdemiology.

Authors:  Edoardo Casiglia; Valérie Tikhonoff
Journal:  Hypertens Res       Date:  2015-03-26       Impact factor: 3.872

2.  Orbitofrontal Neuroadaptations and Cross-Species Synaptic Biomarkers in Heavy-Drinking Macaques.

Authors:  Sudarat Nimitvilai; Joachim D Uys; John J Woodward; Patrick K Randall; Lauren E Ball; Robert W Williams; Byron C Jones; Lu Lu; Kathleen A Grant; Patrick J Mulholland
Journal:  J Neurosci       Date:  2017-03-07       Impact factor: 6.167

3.  Serine hydroxymethyltransferase 1 promoter hypermethylation increases the risk of essential hypertension.

Authors:  Guodong Xu; Changyi Wang; Xiuru Ying; Fanqian Kong; Huihui Ji; Jinshun Zhao; Xiaohong Zhang; Shiwei Duan; Liyuan Han; Li Li
Journal:  J Clin Lab Anal       Date:  2018-11-09       Impact factor: 2.352

4.  A Genome-wide Association Study Discovers 46 Loci of the Human Metabolome in the Hispanic Community Health Study/Study of Latinos.

Authors:  Elena V Feofanova; Han Chen; Yulin Dai; Peilin Jia; Megan L Grove; Alanna C Morrison; Qibin Qi; Martha Daviglus; Jianwen Cai; Kari E North; Cathy C Laurie; Robert C Kaplan; Eric Boerwinkle; Bing Yu
Journal:  Am J Hum Genet       Date:  2020-10-07       Impact factor: 11.025

5.  Interactions between CYP11B2 Promoter Methylation and Smoking Increase Risk of Essential Hypertension.

Authors:  Tianlun Gu; Shuqi Mao; Rui Fan; Fade Zhong; Fubao Zhu; Lingmei Hao; Lina Zhang; Fengying Yin
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

Review 6.  Gene and environmental interactions according to the components of lifestyle modifications in hypertension guidelines.

Authors:  Yoshihiro Kokubo; Sandosh Padmanabhan; Yoshio Iwashima; Kazumasa Yamagishi; Atsushi Goto
Journal:  Environ Health Prev Med       Date:  2019-03-11       Impact factor: 3.674

7.  Elevated UMOD methylation level in peripheral blood is associated with gout risk.

Authors:  Yong Yang; Xiaoying Chen; Haochang Hu; Yuting Jiang; Hang Yu; Jie Dai; Yiyi Mao; Shiwei Duan
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.